Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

BTSG vs ACHC vs SEM vs ENSG vs SGRY

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BTSG
BrightSpring Health Services, Inc. Common Stock

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$10.23B
5Y Perf.+380.4%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-70.2%
SEM
Select Medical Holdings Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$2.04B
5Y Perf.+17.4%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.18B
5Y Perf.+53.9%
SGRY
Surgery Partners, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.87B
5Y Perf.-53.4%

BTSG vs ACHC vs SEM vs ENSG vs SGRY — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BTSG logoBTSG
ACHC logoACHC
SEM logoSEM
ENSG logoENSG
SGRY logoSGRY
IndustryMedical - Healthcare Information ServicesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$10.23B$2.25B$2.04B$10.18B$1.87B
Revenue (TTM)$13.65B$3.37B$5.52B$5.27B$3.34B
Net Income (TTM)$310M$-1.11B$134M$363M$-76M
Gross Margin12.2%56.2%10.6%15.2%22.8%
Operating Margin3.3%11.7%5.8%8.5%11.8%
Forward P/E34.0x16.4x13.1x23.2x38.0x
Total Debt$2.84B$2.65B$3.70B$4.15B$4.02B
Cash & Equiv.$88M$133M$27M$504M$240M

BTSG vs ACHC vs SEM vs ENSG vs SGRYLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BTSG
ACHC
SEM
ENSG
SGRY
StockJan 24May 26Return
BrightSpring Health… (BTSG)100480.4+380.4%
Acadia Healthcare C… (ACHC)10029.8-70.2%
Select Medical Hold… (SEM)100117.4+17.4%
The Ensign Group, I… (ENSG)100153.9+53.9%
Surgery Partners, I… (SGRY)10046.6-53.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: BTSG vs ACHC vs SEM vs ENSG vs SGRY

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Select Medical Holdings Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. BTSG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
BTSG
BrightSpring Health Services, Inc. Common Stock
The Growth Play

BTSG ranks third and is worth considering specifically for growth exposure and valuation efficiency.

  • Rev growth 14.6%, EPS growth 10.3%, 3Y rev CAGR 18.7%
  • PEG 0.70 vs ENSG's 1.68
  • +129.8% vs SGRY's -38.2%
Best for: growth exposure and valuation efficiency
ACHC
Acadia Healthcare Company, Inc.
The Healthcare Pick

ACHC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
SEM
Select Medical Holdings Corporation
The Defensive Pick

SEM is the #2 pick in this set and the best alternative if defensive is your priority.

  • Beta 0.46, yield 1.5%, current ratio 1.04x
  • Lower P/E (13.1x vs 38.0x)
  • 1.5% yield, vs ENSG's 0.1%, (3 stocks pay no dividend)
Best for: defensive
ENSG
The Ensign Group, Inc.
The Income Pick

ENSG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.42, yield 0.1%
  • 7.5% 10Y total return vs BTSG's 381.3%
  • 18.7% revenue growth vs ACHC's 5.0%
  • 6.9% margin vs ACHC's -32.8%
Best for: income & stability and long-term compounding
SGRY
Surgery Partners, Inc.
The Defensive Pick

SGRY is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.04, current ratio 1.87x
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthENSG logoENSG18.7% revenue growth vs ACHC's 5.0%
ValueSEM logoSEMLower P/E (13.1x vs 38.0x)
Quality / MarginsENSG logoENSG6.9% margin vs ACHC's -32.8%
Stability / SafetyENSG logoENSGBeta 0.42 vs BTSG's 1.46
DividendsSEM logoSEM1.5% yield, vs ENSG's 0.1%, (3 stocks pay no dividend)
Momentum (1Y)BTSG logoBTSG+129.8% vs SGRY's -38.2%
Efficiency (ROA)ENSG logoENSG6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9%

BTSG vs ACHC vs SEM vs ENSG vs SGRY — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BTSGBrightSpring Health Services, Inc. Common Stock
FY 2025
Commercial Insurance
68.8%$3.3B
Medicaid
31.2%$1.5B
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B
SEMSelect Medical Holdings Corporation
FY 2025
Health Care, Patient Service, Non-Medicare
61.5%$3.4B
Health Care, Patient Service, Medicare
28.6%$1.6B
Service, Other
9.9%$538M
ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M
SGRYSurgery Partners, Inc.
FY 2025
Healthcare Organization, Patient Service
49.4%$3.2B
Private Insurance
25.8%$1.7B
Government Revenue
21.1%$1.4B
Self-Pay Revenue
1.3%$88M
Other Services
1.3%$82M
Other Patient Service Revenue Sources
1.1%$71M

BTSG vs ACHC vs SEM vs ENSG vs SGRY — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBTSGLAGGINGSGRY

Income & Cash Flow (Last 12 Months)

Evenly matched — BTSG and ENSG each lead in 2 of 6 comparable metrics.

BTSG is the larger business by revenue, generating $13.6B annually — 4.1x SGRY's $3.3B. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, BTSG holds the edge at +25.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
RevenueTrailing 12 months$13.6B$3.4B$5.5B$5.3B$3.3B
EBITDAEarnings before interest/tax$572M$588M$465M$558M$572M
Net IncomeAfter-tax profit$310M-$1.1B$134M$363M-$76M
Free Cash FlowCash after capex$508M-$215M$117M$406M$208M
Gross MarginGross profit ÷ Revenue+12.2%+56.2%+10.6%+15.2%+22.8%
Operating MarginEBIT ÷ Revenue+3.3%+11.7%+5.8%+8.5%+11.8%
Net MarginNet income ÷ Revenue+2.3%-32.8%+2.4%+6.9%-2.3%
FCF MarginFCF ÷ Revenue+3.7%-6.4%+2.1%+7.7%+6.2%
Rev. Growth (YoY)Latest quarter vs prior year+25.6%+7.6%+5.0%+18.4%+4.5%
EPS Growth (YoY)Latest quarter vs prior year+142.9%-49.8%-18.2%+21.9%+6.7%
Evenly matched — BTSG and ENSG each lead in 2 of 6 comparable metrics.

Valuation Metrics

SEM leads this category, winning 3 of 7 comparable metrics.

At 13.9x trailing earnings, SEM trades at a 77% valuation discount to BTSG's 60.9x P/E. Adjusting for growth (PEG ratio), BTSG offers better value at 1.25x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
Market CapShares × price$10.2B$2.3B$2.0B$10.2B$1.9B
Enterprise ValueMkt cap + debt − cash$13.0B$4.8B$5.7B$13.8B$5.7B
Trailing P/EPrice ÷ TTM EPS60.85x-2.01x13.93x29.85x-23.46x
Forward P/EPrice ÷ next-FY EPS est.34.00x16.42x13.06x23.19x37.99x
PEG RatioP/E ÷ EPS growth rate1.25x2.16x
EV / EBITDAEnterprise value multiple22.68x8.27x12.04x25.71x10.00x
Price / SalesMarket cap ÷ Revenue0.79x0.68x0.37x2.01x0.57x
Price / BookPrice ÷ Book value/share6.17x1.04x1.00x4.59x0.52x
Price / FCFMarket cap ÷ FCF25.91x5.33x27.46x9.57x
SEM leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

ENSG leads this category, winning 4 of 9 comparable metrics.

BTSG delivers a 16.7% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. SGRY carries lower financial leverage with a 1.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), BTSG scores 7/9 vs SGRY's 5/9, reflecting strong financial health.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
ROE (TTM)Return on equity+16.7%-40.9%+6.6%+16.6%-2.2%
ROA (TTM)Return on assets+5.0%-18.6%+2.3%+6.8%-0.9%
ROICReturn on invested capital+6.7%+5.9%+4.8%+7.0%+4.1%
ROCEReturn on capital employed+9.0%+7.5%+7.0%+10.2%+5.2%
Piotroski ScoreFundamental quality 0–975555
Debt / EquityFinancial leverage1.51x1.24x1.82x1.86x1.14x
Net DebtTotal debt minus cash$2.8B$2.5B$3.7B$3.7B$3.8B
Cash & Equiv.Liquid assets$88M$133M$27M$504M$240M
Total DebtShort + long-term debt$2.8B$2.7B$3.7B$4.2B$4.0B
Interest CoverageEBIT ÷ Interest expense2.13x-5.99x4.41x88.33x1.35x
ENSG leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BTSG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in BTSG five years ago would be worth $48,127 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, BTSG leads with a +129.8% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors BTSG at 68.8% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
YTD ReturnYear-to-date+37.9%+71.2%+11.4%+0.3%-6.2%
1-Year ReturnPast 12 months+129.8%+1.2%+11.1%+27.5%-38.2%
3-Year ReturnCumulative with dividends+381.3%-64.5%+7.4%+88.9%-59.2%
5-Year ReturnCumulative with dividends+381.3%-61.8%-11.1%+103.2%-72.3%
10-Year ReturnCumulative with dividends+381.3%-58.5%+158.5%+752.0%-0.6%
CAGR (3Y)Annualised 3-year return+68.8%-29.2%+2.4%+23.6%-25.8%
BTSG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BTSG and ENSG each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than BTSG's 1.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTSG currently trades 96.8% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
Beta (5Y)Sensitivity to S&P 5001.46x0.84x0.46x0.42x1.04x
52-Week HighHighest price in past year$54.68$30.20$16.99$218.00$24.18
52-Week LowLowest price in past year$19.01$11.43$11.65$133.81$11.41
% of 52W HighCurrent price vs 52-week peak+96.8%+81.0%+96.8%+80.0%+59.2%
RSI (14)Momentum oscillator 0–10067.946.260.923.363.3
Avg Volume (50D)Average daily shares traded3.0M3.1M2.1M358K1.5M
Evenly matched — BTSG and ENSG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — SEM and ENSG each lead in 1 of 2 comparable metrics.

Analyst consensus: BTSG as "Buy", ACHC as "Buy", SEM as "Hold", ENSG as "Buy", SGRY as "Buy". Consensus price targets imply 30.0% upside for SGRY (target: $19) vs -7.9% for BTSG (target: $49). For income investors, SEM offers the higher dividend yield at 1.55% vs ENSG's 0.14%.

MetricBTSG logoBTSGBrightSpring Heal…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…ENSG logoENSGThe Ensign Group,…SGRY logoSGRYSurgery Partners,…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyBuy
Price TargetConsensus 12-month target$48.75$23.50$18.00$222.33$18.60
# AnalystsCovering analysts925131322
Dividend YieldAnnual dividend ÷ price+1.5%+0.1%
Dividend StreakConsecutive years of raises10120
Dividend / ShareAnnual DPS$0.25$0.24
Buyback YieldShare repurchases ÷ mkt cap+0.4%+2.2%+4.9%+0.2%0.0%
Evenly matched — SEM and ENSG each lead in 1 of 2 comparable metrics.
Key Takeaway

SEM leads in 1 of 6 categories (Valuation Metrics). ENSG leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallBrightSpring Health Service… (BTSG)Leads 1 of 6 categories
Loading custom metrics...

BTSG vs ACHC vs SEM vs ENSG vs SGRY: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BTSG or ACHC or SEM or ENSG or SGRY a better buy right now?

For growth investors, The Ensign Group, Inc.

(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate BrightSpring Health Services, Inc. Common Stock (BTSG) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BTSG or ACHC or SEM or ENSG or SGRY?

On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.

9x versus BrightSpring Health Services, Inc. Common Stock at 60. 9x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: BrightSpring Health Services, Inc. Common Stock wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — BTSG or ACHC or SEM or ENSG or SGRY?

Over the past 5 years, BrightSpring Health Services, Inc.

Common Stock (BTSG) delivered a total return of +381. 3%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BTSG or ACHC or SEM or ENSG or SGRY?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus BrightSpring Health Services, Inc. Common Stock's 1. 46β — meaning BTSG is approximately 247% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Surgery Partners, Inc. (SGRY) carries a lower debt/equity ratio of 114% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BTSG or ACHC or SEM or ENSG or SGRY?

By revenue growth (latest reported year), The Ensign Group, Inc.

(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: BrightSpring Health Services, Inc. Common Stock grew EPS 1029% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, BTSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BTSG or ACHC or SEM or ENSG or SGRY?

The Ensign Group, Inc.

(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus 3. 2% for BTSG. At the gross margin level — before operating expenses — SGRY leads at 23. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BTSG or ACHC or SEM or ENSG or SGRY more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, BrightSpring Health Services, Inc. Common Stock (BTSG) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13. 1x forward P/E versus 38. 0x for Surgery Partners, Inc. — 24. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SGRY: 30. 0% to $18. 60.

08

Which pays a better dividend — BTSG or ACHC or SEM or ENSG or SGRY?

In this comparison, SEM (1.

5% yield), ENSG (0. 1% yield) pay a dividend. BTSG, ACHC, SGRY do not pay a meaningful dividend and should not be held primarily for income.

09

Is BTSG or ACHC or SEM or ENSG or SGRY better for a retirement portfolio?

For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, BTSG: +381. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BTSG and ACHC and SEM and ENSG and SGRY?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BTSG is a mid-cap quality compounder stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock; ENSG is a mid-cap high-growth stock; SGRY is a small-cap quality compounder stock. SEM pays a dividend while BTSG, ACHC, ENSG, SGRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BTSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 12%
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

SEM

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.6%
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Stocks Like

SGRY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BTSG and ACHC and SEM and ENSG and SGRY on the metrics below

Revenue Growth>
%
(BTSG: 25.6% · ACHC: 7.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.